Literature DB >> 34051983

AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease.

Joseph D Feuerstein1, Edith Y Ho2, Eugenia Shmidt3, Harminder Singh4, Yngve Falck-Ytter5, Shanaz Sultan3, Jonathan P Terdiman6.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34051983      PMCID： PMC8988893          DOI： 10.1053/j.gastro.2021.04.022

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   33.883


× No keyword cloud information.
  25 in total

1.  Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial.

Authors:  Geert D'Haens; Filip Baert; Gert van Assche; Philip Caenepeel; Philippe Vergauwe; Hans Tuynman; Martine De Vos; Sander van Deventer; Larry Stitt; Allan Donner; Severine Vermeire; Frank J Van De Mierop; Jean-Charles R Coche; Janneke van der Woude; Thomas Ochsenkühn; Ad A van Bodegraven; Philippe P Van Hootegem; Guy L Lambrecht; Fazia Mana; Paul Rutgeerts; Brian G Feagan; Daniel Hommes
Journal:  Lancet       Date:  2008-02-23       Impact factor: 79.321

Review 2.  Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies.

Authors:  Alexandra D Frolkis; Jonathan Dykeman; María E Negrón; Jennifer Debruyn; Nathalie Jette; Kirsten M Fiest; Talia Frolkis; Herman W Barkema; Kevin P Rioux; Remo Panaccione; Subrata Ghosh; Samuel Wiebe; Gilaad G Kaplan
Journal:  Gastroenterology       Date:  2013-07-27       Impact factor: 22.682

3.  The AGA institute process for developing clinical practice guidelines part one: grading the evidence.

Authors:  Shahnaz Sultan; Yngve Falck-Ytter; John M Inadomi
Journal:  Clin Gastroenterol Hepatol       Date:  2013-04       Impact factor: 11.382

4.  Maintenance of remission among patients with Crohn's disease on antimetabolite therapy after infliximab therapy is stopped.

Authors:  Edouard Louis; Jean-Yves Mary; Gwenola Vernier-Massouille; Jean-Charles Grimaud; Yoram Bouhnik; David Laharie; Jean-Louis Dupas; Hélène Pillant; Laurence Picon; Michel Veyrac; Mathurin Flamant; Guillaume Savoye; Raymond Jian; Martine Devos; Raphaël Porcher; Gilles Paintaud; Eric Piver; Jean-Frédéric Colombel; Marc Lemann
Journal:  Gastroenterology       Date:  2011-09-22       Impact factor: 22.682

5.  Natural disease course of Crohn's disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study.

Authors:  Johan Burisch; Gediminas Kiudelis; Limas Kupcinskas; Hendrika Adriana Linda Kievit; Karina Winther Andersen; Vibeke Andersen; Riina Salupere; Natalia Pedersen; Jens Kjeldsen; Renata D'Incà; Daniela Valpiani; Doron Schwartz; Selwyn Odes; Jóngerð Olsen; Kári Rubek Nielsen; Zsuzsanna Vegh; Peter Laszlo Lakatos; Alina Toca; Svetlana Turcan; Konstantinos H Katsanos; Dimitrios K Christodoulou; Mathurin Fumery; Corinne Gower-Rousseau; Stefania Chetcuti Zammit; Pierre Ellul; Carl Eriksson; Jonas Halfvarson; Fernando Jose Magro; Dana Duricova; Martin Bortlik; Alberto Fernandez; Vicent Hernández; Sally Myers; Shaji Sebastian; Pia Oksanen; Pekka Collin; Adrian Goldis; Ravi Misra; Naila Arebi; Ioannis P Kaimakliotis; Inna Nikuina; Elena Belousova; Marko Brinar; Silvija Cukovic-Cavka; Ebbe Langholz; Pia Munkholm
Journal:  Gut       Date:  2018-01-23       Impact factor: 23.059

6.  Decreasing Risk of First and Subsequent Surgeries in Patients With Crohn's Disease in England From 1994 through 2013.

Authors:  Nicholas E Burr; Richard Lord; Mark A Hull; Venkataraman Subramanian
Journal:  Clin Gastroenterol Hepatol       Date:  2018-12-21       Impact factor: 11.382

7.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

Authors:  W R Best; J M Becktel; J W Singleton; F Kern
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

Review 8.  Crohn's disease.

Authors:  Joana Torres; Saurabh Mehandru; Jean-Frédéric Colombel; Laurent Peyrin-Biroulet
Journal:  Lancet       Date:  2016-12-01       Impact factor: 79.321

Review 9.  Effects of Race and Ethnicity on Diagnosis and Management of Inflammatory Bowel Diseases.

Authors:  Edward L Barnes; Edward V Loftus; Michael D Kappelman
Journal:  Gastroenterology       Date:  2020-10-21       Impact factor: 22.682

Review 10.  AGA Technical Review on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease.

Authors:  Siddharth Singh; Deborah Proctor; Frank I Scott; Yngve Falck-Ytter; Joseph D Feuerstein
Journal:  Gastroenterology       Date:  2021-06       Impact factor: 33.883
View more
  23 in total

Review 1.  A review of the therapeutic management of Crohn's disease.

Authors:  Aditi Kumar; Alexander Cole; Jonathan Segal; Philip Smith; Jimmy K Limdi
Journal:  Therap Adv Gastroenterol       Date:  2022-02-17       Impact factor: 4.409

2.  Editorial: risk of pneumonia in IBD-reading between the lines!

Authors:  Joseph Meserve; Siddharth Singh
Journal:  Aliment Pharmacol Ther       Date:  2021-12       Impact factor: 8.171

Review 3.  Certolizumab pegol for maintenance of medically induced remission in Crohn's disease.

Authors:  Shinji Okabayashi; Hajime Yamazaki; Ryohei Yamamoto; Keisuke Anan; Katsuyoshi Matsuoka; Taku Kobayashi; Shinichiro Shinzaki; Yusuke Honzawa; Yuki Kataoka; Yasushi Tsujimoto; Norio Watanabe
Journal:  Cochrane Database Syst Rev       Date:  2022-06-30

Review 4.  Efficacy and safety of FiLaC™ for perianal fistulizing Crohn's disease: a systematic review and meta-analysis.

Authors:  D Cao; W Li; X Wang; Y Ji; Z Cui
Journal:  Tech Coloproctol       Date:  2022-08-12       Impact factor: 3.699

5.  Interactive Inflammatory Bowel Disease Biologics Decision Aid Does Not Improve Patient Outcomes Over Static Education: Results From a Randomized Trial.

Authors:  Christopher V Almario; Welmoed K van Deen; Michelle Chen; Rebecca Gale; Stéphanie Sidorkiewicz; So Yung Choi; Nirupama Bonthala; Christina Ha; Gaurav Syal; Taylor Dupuy; Xiaoyu Liu; Gil Y Melmed; Brennan M R Spiegel
Journal:  Am J Gastroenterol       Date:  2022-06-10       Impact factor: 12.045

6.  Distinct alterations of fecal microbiota refer to the efficacy of adalimumab in Crohn's disease.

Authors:  Liang Chen; Zhanjun Lu; Dengfeng Kang; Zhongsheng Feng; Gengfeng Li; Mingming Sun; Zhanju Liu; Wei Wu; Leilei Fang
Journal:  Front Pharmacol       Date:  2022-08-11       Impact factor: 5.988

Review 7.  Inflammatory Bowel Disease Treatments and Predictive Biomarkers of Therapeutic Response.

Authors:  Duaa Ahmed Elhag; Manoj Kumar; Marwa Saadaoui; Anthony K Akobeng; Fatma Al-Mudahka; Mamoun Elawad; Souhaila Al Khodor
Journal:  Int J Mol Sci       Date:  2022-06-23       Impact factor: 6.208

8.  Epidemiology and Natural History of Perianal Crohn's Disease: A Systematic Review and Meta-Analysis of Population-Based Cohorts.

Authors:  Lester Tsai; Jeffrey D McCurdy; Christopher Ma; Vipul Jairath; Siddharth Singh
Journal:  Inflamm Bowel Dis       Date:  2022-10-03       Impact factor: 7.290

9.  No Benefit of Continuing 5-Aminosalicylates in Patients with Crohn's Disease Treated with Anti-metabolite Therapy.

Authors:  Dominic Picetti; Jihoon Kim; Wenhong Zhu; William J Sandborn; Vipul Jairath; Siddharth Singh
Journal:  Dig Dis Sci       Date:  2021-11-19       Impact factor: 3.487

10.  Efficacy and tolerability of hyperbaric oxygen therapy in small bowel stricturing Crohn's disease: a pilot study.

Authors:  Bhaskar Kante; Pabitra Sahu; Saurabh Kedia; Sudheer K Vuyyuru; Kapil Soni; Maneesh Singhal; Raju Sharma; Govind Makharia; Vineet Ahuja
Journal:  Intest Res       Date:  2022-02-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.